Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Nectar Life
Nectar Life
BSE: 532649NSE: NECLIFEISIN: INE023H01027

25th-May-2019 16:52Source: BSE

Nectar Lifesciences - Outcome of Board Meeting

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in their meeting held on May 25, 2019 have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the company, out of profits of the company for the financial year 2018-2019, subject to the approval of the members in their Annual General Meeting.

Sections
Follow us on
Available On
PCI DSS Compliant